164 related articles for article (PubMed ID: 19025862)
21. Determination of beta-amyloid peptide signatures in cerebrospinal fluid using immunoprecipitation-mass spectrometry.
Portelius E; Westman-Brinkmalm A; Zetterberg H; Blennow K
J Proteome Res; 2006 Apr; 5(4):1010-6. PubMed ID: 16602710
[TBL] [Abstract][Full Text] [Related]
22. Molecular dynamics study of the beta amyloid peptide of Alzheimer's disease and its divalent copper complexes.
Raffa DF; Rauk A
J Phys Chem B; 2007 Apr; 111(14):3789-99. PubMed ID: 17388547
[TBL] [Abstract][Full Text] [Related]
23. Amphotericin B interactions with soluble oligomers of amyloid Abeta1-42 peptide.
Smith NW; Annunziata O; Dzyuba SV
Bioorg Med Chem; 2009 Mar; 17(6):2366-70. PubMed ID: 19268601
[TBL] [Abstract][Full Text] [Related]
24. Isopeptide method: development of S-acyl isopeptide method for the synthesis of difficult sequence-containing peptides.
Yoshiya T; Ito N; Kimura T; Kiso Y
J Pept Sci; 2008 Nov; 14(11):1203-8. PubMed ID: 18613286
[TBL] [Abstract][Full Text] [Related]
25. Interaction of beta-amyloid(1-40) peptide with pairs of metal ions: An electrospray ion trap mass spectrometric model study.
Drochioiu G; Manea M; Dragusanu M; Murariu M; Dragan ES; Petre BA; Mezo G; Przybylski M
Biophys Chem; 2009 Sep; 144(1-2):9-20. PubMed ID: 19539421
[TBL] [Abstract][Full Text] [Related]
26. Structural characterization of a soluble amyloid beta-peptide oligomer.
Yu L; Edalji R; Harlan JE; Holzman TF; Lopez AP; Labkovsky B; Hillen H; Barghorn S; Ebert U; Richardson PL; Miesbauer L; Solomon L; Bartley D; Walter K; Johnson RW; Hajduk PJ; Olejniczak ET
Biochemistry; 2009 Mar; 48(9):1870-7. PubMed ID: 19216516
[TBL] [Abstract][Full Text] [Related]
27. Direct in vivo intracellular selection of conformation-sensitive antibody domains targeting Alzheimer's amyloid-beta oligomers.
Meli G; Visintin M; Cannistraci I; Cattaneo A
J Mol Biol; 2009 Apr; 387(3):584-606. PubMed ID: 19361429
[TBL] [Abstract][Full Text] [Related]
28. Design, synthesis, and biophysical properties of a helical Abeta1-42 analog: Inhibition of fibrillogenesis and cytotoxicity.
Matsuzaki K; Okada T; Tsukuda M; Ikeda K; Sohma Y; Chiyomori Y; Taniguchi A; Nakamura S; Ito N; Hayashi Y; Kiso Y
Biochem Biophys Res Commun; 2008 Jul; 371(4):777-80. PubMed ID: 18471993
[TBL] [Abstract][Full Text] [Related]
29. Intramolecular charge interactions as a tool to control the coiled-coil-to-amyloid transformation.
Pagel K; Wagner SC; Rezaei Araghi R; von Berlepsch H; Böttcher C; Koksch B
Chemistry; 2008; 14(36):11442-51. PubMed ID: 19016556
[TBL] [Abstract][Full Text] [Related]
30. Pyroglutamate formation influences solubility and amyloidogenicity of amyloid peptides.
Schlenzig D; Manhart S; Cinar Y; Kleinschmidt M; Hause G; Willbold D; Funke SA; Schilling S; Demuth HU
Biochemistry; 2009 Jul; 48(29):7072-8. PubMed ID: 19518051
[TBL] [Abstract][Full Text] [Related]
31. Identification of novel APP/Abeta isoforms in human cerebrospinal fluid.
Portelius E; Brinkmalm G; Tran AJ; Zetterberg H; Westman-Brinkmalm A; Blennow K
Neurodegener Dis; 2009; 6(3):87-94. PubMed ID: 19229112
[TBL] [Abstract][Full Text] [Related]
32. Aminopeptidase A contributes to the N-terminal truncation of amyloid beta-peptide.
Sevalle J; Amoyel A; Robert P; Fournié-Zaluski MC; Roques B; Checler F
J Neurochem; 2009 Apr; 109(1):248-56. PubMed ID: 19187443
[TBL] [Abstract][Full Text] [Related]
33. Study of the specific lipid binding properties of Abeta 11-22 fragment at endosomal pH.
Ravault S; Flore C; Saurel O; Milon A; Brasseur R; Lins L
Langmuir; 2009 Sep; 25(18):10948-53. PubMed ID: 19735146
[TBL] [Abstract][Full Text] [Related]
34. Antiparallel beta-sheet: a signature structure of the oligomeric amyloid beta-peptide.
Cerf E; Sarroukh R; Tamamizu-Kato S; Breydo L; Derclaye S; Dufrêne YF; Narayanaswami V; Goormaghtigh E; Ruysschaert JM; Raussens V
Biochem J; 2009 Jul; 421(3):415-23. PubMed ID: 19435461
[TBL] [Abstract][Full Text] [Related]
35. N-terminal truncated pyroglutamyl beta amyloid peptide Abetapy3-42 shows a faster aggregation kinetics than the full-length Abeta1-42.
D'Arrigo C; Tabaton M; Perico A
Biopolymers; 2009 Oct; 91(10):861-73. PubMed ID: 19562755
[TBL] [Abstract][Full Text] [Related]
36. Conformational preferences of a short Aib/Ala-based water-soluble peptide as a function of temperature.
Banerjee R; Chattopadhyay S; Basu G
Proteins; 2009 Jul; 76(1):184-200. PubMed ID: 19137603
[TBL] [Abstract][Full Text] [Related]
37. Simultaneous analysis by capillary electrophoresis of five amyloid peptides as potential biomarkers of Alzheimer's disease.
Verpillot R; Otto M; Klafki H; Taverna M
J Chromatogr A; 2008 Dec; 1214(1-2):157-64. PubMed ID: 18992892
[TBL] [Abstract][Full Text] [Related]
38. Preparation of amyloid beta-protein for structural and functional studies.
Teplow DB
Methods Enzymol; 2006; 413():20-33. PubMed ID: 17046389
[TBL] [Abstract][Full Text] [Related]
39. 'O-Acyl isopeptide method' for peptide synthesis: Solvent effects in the synthesis of Abeta1-42 isopeptide using 'O-acyl isodipeptide unit'.
Taniguchi A; Yoshiya T; Abe N; Fukao F; Sohma Y; Kimura T; Hayashi Y; Kiso Y
J Pept Sci; 2007 Dec; 13(12):868-74. PubMed ID: 17803257
[TBL] [Abstract][Full Text] [Related]
40. A new class of aggregation inhibitor of amyloid-β peptide based on an O-acyl isopeptide.
Kawashima H; Sohma Y; Nakanishi T; Kitamura H; Mukai H; Yamashita M; Akaji K; Kiso Y
Bioorg Med Chem; 2013 Nov; 21(21):6323-7. PubMed ID: 24076366
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
